Owkin, Sanofi expand AI collaboration to build drug development AI agents
Posted:
Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development.
AI-driven billing for more medically complex inpatient stays has resulted in nearly $1 billion in additional healthcare costs over the last two years, according to new analysis by the Blue Cross Blue Shield Association.
More than 60% of hospitals and…
An artificial intelligence (AI) algorithm increased aneurysm detection, identifying 55 true-positive brain aneurysms that radiologists had missed, representing a 39% relative increase in detection.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us